Travere Therapeutics stock falls amid CEO transition news
UKPulse Markets Desk
Travere Therapeutics shares fell following news of a chief executive transition. No further details were available in the source.
- Travere Therapeutics stock fell amid CEO transition news.
- The source provided no further details on the transition.
Travere Therapeutics stock fell amid news of a chief executive transition, according to a report from Investing.com UK dated 21 September 2026.
No further details of the transition, including the identity of any incoming or outgoing chief executive or the timing of the change, were available in the source material.